IRIDEX CORP
For the period ended Mar 29, 2025. Filed May 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 13, 2025
What changed in Risk Factors?
Read the current filingPrevious report: 10-Q
Period ended 2024-09-28; filed 2024-11-12.
0000950170-24-125541
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresCurrent report: 10-Q
Period ended 2025-03-29; filed 2025-05-13.
0000950170-25-070469
Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of ProceedsDefaults Upon Senior SecuritiesMine Safety DisclosuresThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 265 previous paragraphs and 9 current paragraphs.
8 unchanged; 1 reworded; 0 added; 256 removed; 0 previous and 0 current paragraphs rearranged.
Tables are not compared: 0 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Removed paragraphs (256)
Previous report
Our business operations are subject to numerous risks, factors and uncertainties outside of our control that could cause our actual results to be harmed, including risks regarding the following:
Previous report
general macroeconomic conditions, including inflationary pressures and changing interest rates, a reduction in business confidence and activity, global pandemics and responsive measures and the Russia-Ukraine and Israel-Hamas conflicts.
Previous report
we may need additional funding and may not be able to raise capital when needed, which could force us to delay or reduce commercialization efforts;
Previous report
our financial condition raises serious doubt as to our ability to continue to operate as a going concern;
Previous report
our convertible note agreement contains restrictive and financial covenants that may limit our operating flexibility and the failure to comply with such covenants could cause our outstanding debt to become accelerated;
Previous report
the success of our relationship with our strategic partner and main distributor Topcon;
Previous report
direct and independent sales forces and a network of international distributors to sell our products;
Previous report
new products and applications and improving existing products;
Previous report
fluctuations in our sales and operating results;
Previous report
the collaborative relationships used to enhance products and applications;
Previous report
costs, sales volumes, results of operations, and revenues;
Previous report
dependence on sole source and limited source suppliers;
Previous report
disruptions to our information technology system and breaches of data security;
Previous report
maintaining relationships with health-care providers;
Previous report
the inability of our customers to obtain credit or material increases in interest rates;
Previous report
healthcare reform measures and changes in third-party coverage and reimbursement policies;
Previous report
our compliance with potential governmental, regulatory and other legal proceedings relative to advertising, promotion and marketing;
Previous report
patents and proprietary rights related to our intellectual property;
Previous report
compliance with government regulations, including the FDA’s quality system regulation and laser performance standards;
Showing the first 40 of 256 passages. Open the source sections for the rest.
Reworded paragraphs (1)
Previous wording
Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below, together with all of the other information in this Quarterly Report on Form 10-Q, including the sections titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our condensed consolidated financial statements and related notes, before making a decision to invest in our common stock. Our business, financial condition, results of operations, or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations, and prospects could be adversely affected. In that event, the market price of our common stock could decline, and you could lose part or all of your investment.
Current wording
An investment in our securities has a high degree of risk. Before you invest you should carefully consider the risks and uncertainties. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial conditions and/or operating results. If any of these risks actually occur, our business, operating results and financial condition could be harmed, and the value of our stock could go down. This means you could lose all or a part of your investment. We have included in Part I, Item 1A in our Annual Report on Form 10-K for the year ended December 28, 2024, which was filed with the SEC on March 27, 2025, a description of certain risks and uncertainties that could affect our business, future performance or financial condition (the “Risk Factors”). There have been no material changes from the disclosure provided in the Form 10-K with respect to the Risk Factors.